| 1 | Publication bias: what is it? How do we measure it? How do w… (10.2147/oajct.s34419) | Abstract References ORCID | 173.54 | 205 |
| 2 | Clinical data management: Current status, challenges, and fu… (10.2147/oajct.s8172) | Abstract References ORCID | 128.07 | 50 |
| 3 | Examining the readability of patient-informed consent forms (10.2147/oajct.s13608) | Abstract References ORCID | 110.78 | 29 |
| 4 | Biology and natural history of human papillomavirus infectio… (10.2147/oajct.s37741) | Abstract References ORCID | 103.52 | 23 |
| 5 | TRANSFORM: a novel study design to evaluate the effect of ev… (10.2147/oajct.s63058) | Abstract References ORCID | 99.17 | 20 |
| 6 | Randomized controlled trial of a positive affect interventio… (10.2147/oajct.s64645) | Abstract References ORCID | 99.17 | 20 |
| 7 | Phase I dose-escalation trial of intravaginal curcumin in wo… (10.2147/oajct.s105010) | Abstract References ORCID | 97.58 | 19 |
| 8 | Nonsurgical treatment of hemifacial microsomia by therapeuti… (10.2147/oajct.s7060) | Abstract References ORCID | 97.58 | 19 |
| 9 | Cranberry syrup vs trimethoprim in the prophylaxis of recurr… (10.2147/oajct.s31734) | Abstract References ORCID | 95.91 | 18 |
| 10 | Conducting clinical trials in emerging markets of sub-Sahara… (10.2147/oajct.s77316) | Abstract References ORCID | 92.28 | 16 |
| 11 | Implementing good participatory practice guidelines in the F… (10.2147/oajct.s45717) | Abstract References ORCID | 90.31 | 15 |
| 12 | <p>Taking Optogenetics into the Human Brain: Opportuni… (10.2147/oajct.s259702) | Abstract ORCID | 86.21 | 52 |
| 13 | Study design and patient recruitment for the Japan Polyp Stu… (10.2147/oajct.s62272) | Abstract References ORCID | 85.96 | 13 |
| 14 | Data retention after a patient withdraws consent in clinical… (10.2147/oajct.s13960) | Abstract References ORCID | 83.55 | 12 |
| 15 | Neuropsychiatric symptoms in dementia and the effects of Gin… (10.2147/oajct.s93531) | Abstract References ORCID | 80.94 | 11 |
| 16 | <p>MCLENA-1: A Phase II Clinical Trial for the Assessm… (10.2147/oajct.s221914) | Abstract References | 80.10 | 39 |
| 17 | Activities of key glycolytic enzymes in the plasma of Saudi… (10.2147/oajct.s8074) | Abstract References ORCID | 78.10 | 10 |
| 18 | The role of functional, social, and mobility dynamics in fac… (10.2147/oajct.s122422) | Abstract References ORCID | 75.00 | 9 |
| 19 | The Functional Ambulation: Standard Treatment versus Electri… (10.2147/oajct.s40057) | Abstract References ORCID | 75.00 | 9 |
| 20 | Selective enhancement of focused attention by <em>Alpi… (10.2147/oajct.s164450) | Abstract References ORCID | 71.57 | 8 |
| 21 | Analyzing noninferiority trials: it is time for advantage de… (10.2147/oajct.s74821) | Abstract References ORCID | 71.57 | 8 |
| 22 | Pharmacological modeling and biostatistical analysis of a ne… (10.2147/oajct.s9290) | Abstract References ORCID | 71.57 | 8 |
| 23 | Variation in effect of intervention studies in research on s… (10.2147/oajct.s25651) | Abstract References ORCID | 67.73 | 7 |
| 24 | Efficacy of the anti-VZV (anti-HSV3) vaccine in HSV1 and HSV… (10.2147/oajct.s33292) | Abstract References ORCID | 67.73 | 7 |
| 25 | Global mental health intervention research and mass trauma (10.2147/oajct.s37037) | Abstract References ORCID | 67.73 | 7 |
| 26 | Automated patient and medication payment method for clinical… (10.2147/oajct.s38489) | Abstract References ORCID | 67.73 | 7 |
| 27 | Time will tell: community acceptability of HIV vaccine resea… (10.2147/oajct.s11915) | Abstract References ORCID | 63.38 | 6 |
| 28 | Improving efficiency in cluster-randomized study design and… (10.2147/oajct.s56730) | Abstract References ORCID | 63.38 | 6 |
| 29 | Opioid growth factor improves clinical benefit and survival… (10.2147/oajct.s8270) | Abstract References ORCID | 63.38 | 6 |
| 30 | A randomized controlled trial to improve heart failure dispa… (10.2147/oajct.s136066) | Abstract References ORCID | 58.36 | 5 |
| 31 | Subjective endpoints in clinical trials: the case for blinde… (10.2147/oajct.s50283) | Abstract References ORCID | 58.36 | 5 |
| 32 | Challenges with engaging participants in behavioral interven… (10.2147/oajct.s6841) | Abstract References ORCID | 58.36 | 5 |
| 33 | Influences upon pediatricians&rsquo; willingness to refe… (10.2147/oajct.s8244) | Abstract References ORCID | 58.36 | 5 |
| 34 | Design, and participant enrollment, of a randomized controll… (10.2147/oajct.s82533) | Abstract References ORCID | 58.36 | 5 |
| 35 | <p>An evaluation of informed consent comprehension by… (10.2147/oajct.s145068) | Abstract References | 53.96 | 11 |
| 36 | Life Enhancing Activities for Family Caregivers of people wi… (10.2147/oajct.s150597) | Abstract References | 53.96 | 11 |
| 37 | Post-Trial Considerations for an Early Phase Optogenetic Tri… (10.2147/oajct.s345482) | Abstract ORCID | 53.96 | 11 |
| 38 | The effects of heterogeneity on Simon Phase II clinical tria… (10.2147/oajct.s10470) | Abstract References ORCID | 52.42 | 4 |
| 39 | A data-capture system for post-marketing surveillance of dru… (10.2147/oajct.s19579) | Abstract References ORCID | 52.42 | 4 |
| 40 | The influence of the nocebo effect in clinical trials (10.2147/oajct.s33730) | Abstract References ORCID | 52.42 | 4 |
| 41 | Between- and within-patient n-level response surface pathway… (10.2147/oajct.s57955) | Abstract References ORCID | 52.42 | 4 |
| 42 | A televideo exercise and nutrition program for children with… (10.2147/oajct.s83292) | Abstract References ORCID | 52.42 | 4 |
| 43 | Evaluation of medication errors with implementation of elect… (10.2147/oajct.s131211) | Abstract References | 52.07 | 10 |
| 44 | <p>The Challenges In Conducting Research Studies In Ar… (10.2147/oajct.s215738) | Abstract References | 50.00 | 9 |
| 45 | An international, multicenter, observational survey to evalu… (10.2147/oajct.s103459) | Abstract References ORCID | 45.15 | 3 |
| 46 | Efficacy and safety of two fast-absorbing formulations of pa… (10.2147/oajct.s133629) | Abstract References ORCID | 45.15 | 3 |
| 47 | Phase II trial of second-line erlotinib and digoxin for nons… (10.2147/oajct.s16347) | Abstract References ORCID | 45.15 | 3 |
| 48 | Assessment of the efficacy of first-line antimalarial drugs… (10.2147/oajct.s24687) | Abstract References ORCID | 45.15 | 3 |
| 49 | Design of a prospective, multinational registry to evaluate… (10.2147/oajct.s49421) | Abstract References ORCID | 45.15 | 3 |
| 50 | Bridging the Past and Future of Clinical Data Management: Th… (10.2147/oajct.s509921) | Abstract References | 45.15 | 7 |